glp-1 receptor agonists hydration recommendations and beyond. Part 1: benefits in type 2 diabetes GLP-1 and the kidney: from

Brenzavvy (bexagliflozin) [package insert]

We take the time to explain how GLP1 therapy works, outline potential side effects, and provide a clear plan for achieving safe and effective results

Tirzepatide has received approval for use in patients with T2D following several phase 3 studies testing and demonstrating its marked anti-hyperglycemic efficacy and positive actions on multiple cardiovascular risk factors, associated with an excellent safety profile [2, 3]

Arterioscler Thromb Vasc Biol 2013

Furthermore, we did not use operationalized criteria (for example, Diagnostic and Statistical Manual 5th edition) to define the populations of interest because these would not be applicable across animal and human studies, but instead relied on the definitions provided by the individual articles